Switdapa-M 10/500 XR Tablet
Marketer
Akumentis Healthcare Ltd
Salt Composition
Dapagliflozin (10mg) + Metformin (500mg)
Overview Switdapa-M 10/500 XR Tablet
Diabex Duo 10/500 XR tablets combine two medications to manage type 2 diabetes. This dual-action formulation regulates elevated blood glucose, mitigating the risk of severe diabetic complications and potentially reducing heart disease risk. Diabex Duo 10/500 XR can be ingested with meals; consistent daily dosing, as prescribed by your physician, is crucial for efficacy. Discontinuing treatment without medical supervision may lead to uncontrolled blood sugar, potentially resulting in serious consequences such as renal impairment or vision loss. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight control as recommended by your doctor. Commonly reported side effects include upper respiratory discomfort (sore throat, nasal congestion, rhinorrhea), headache, gastrointestinal upset (nausea, vomiting, diarrhea). Adequate hydration is important to prevent dehydration. Genital fungal infections are a potential side effect; good hygiene practices can help minimize this risk. Prior to initiating treatment, inform your doctor of any kidney or liver disease, urinary tract infections, diuretic use, or pregnancy/breastfeeding status. Limit alcohol consumption while on this medication to lessen the possibility of increased side effects. Regular blood glucose monitoring is essential throughout treatment.
Primary Ingredients of Switdapa-M 10/500 XR Tablet
No information provided. Please provide the text you wish to be rephrased.
Uses of Switdapa-M 10/500 XR Tablet
Managing type 2 diabetes
Major Benefits of Switdapa-M 10/500 XR Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Switdapa-M 10/500 XR Tablet whole; avoid crushing, chewing, or breaking it. Administer this medication with food.
Common Side effects of Switdapa-M 10/500 XR Tablet:
- Nausea
- Vomiting
- Diarrhea
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
- Polyuria
- Flatulence
- Skin rash
- Taste change
- Difficulty in urination
- Hypoglycemia (low blood glucose level)
- Tremors
- Dizziness
- Back pain
- Increased hematocrit
- Decreased creatinine clearance
- Dyslipidemia
How to use Switdapa-M 10/500 XR Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Switdapa-M 10/500 XR Tablet whole; do not damage or alter its form in any way. Administer this medicine with a meal.
How Switdapa-M 10/500 XR Tablet works:
The extended-release tablet, Switdapa-M 10/500 XR, merges dapagliflozin and metformin to manage diabetes. Dapagliflozin facilitates glucose excretion via the kidneys, while metformin reduces hepatic glucose production, slows intestinal glucose uptake, and enhances insulin responsiveness. This dual action optimizes blood glucose regulation.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Switdapa-M 10/500 XR Tablets is not recommended due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Use of Switdapa-M 10/500 XR Tablet during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Switdapa-M 10/500 tablet is likely not safe for breastfeeding mothers. Scant clinical evidence indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Switdapa-M 10/500 XR tablets cautiously, as dose modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Switdapa-M 10/500 XR tablets. Dosage modification may be necessary; physician consultation is advised.
What if you forget to take Switdapa-M 10/500 XR Tablet :
Should you forget a Switdapa-M 10/500 XR Tablet dose, ingest it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Switdapa-M 10/500 XR Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |



